Search research articles
Contact Us
Filters
Showing results (191-200 of 1,725) with videos related to
Page
of 173
Sort By:
Clinical and Experimental Rheumatology
|
October 17, 2013
The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials
Arthur Kavanaugh, Josef S Smolen
Clinical and Experimental Rheumatology
|
November 4, 2014
Scores for all seasons: SDAI and CDAI
J S Smolen, D Aletaha
Nature Clinical Practice. Rheumatology
|
May 8, 2008
Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Arthritis and Rheumatism
|
May 20, 1998
Mixed connective tissue disease: to be or not to be?
J S Smolen, G Steiner
JAMA
|
October 5, 2018
Diagnosis and Management of Rheumatoid Arthritis: A Review
Daniel Aletaha, Josef S Smolen
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
January 1, 1987
The role of neuron death in the development of the gender difference in the number of neurons in the rat superior cervical ganglion
L L Wright, A J Smolen
Social Biology
|
January 1, 1985
Neurochemical mechanisms in the genetics of alcohol phenotypes
T N Smolen, A C Collins
Journal of Lipid Research
|
May 1, 1974
Permeability changes induced by peroxidation in liposomes prepared from human erythrocyte lipids
J E Smolen, S B Shohet
Journal of Pharmaceutical Sciences
|
March 1, 1977
Predictive conversion of in vitro drug dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarin
V F Smolen, R J Erb
The Journal of Experimental Medicine
|
September 14, 2016
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor
Eng M Tan, Josef S Smolen
Page
of 173
Search research articles
Search
Showing results (191-200 of 1,725) with videos related to
Sort By:
Page
of 173
Clinical and Experimental Rheumatology
|
October 17, 2013
The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials
Arthur Kavanaugh, Josef S Smolen
Clinical and Experimental Rheumatology
|
November 4, 2014
Scores for all seasons: SDAI and CDAI
J S Smolen, D Aletaha
Nature Clinical Practice. Rheumatology
|
May 8, 2008
Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis
Josef S Smolen, Daniel Aletaha
Arthritis and Rheumatism
|
May 20, 1998
Mixed connective tissue disease: to be or not to be?
J S Smolen, G Steiner
JAMA
|
October 5, 2018
Diagnosis and Management of Rheumatoid Arthritis: A Review
Daniel Aletaha, Josef S Smolen
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
January 1, 1987
The role of neuron death in the development of the gender difference in the number of neurons in the rat superior cervical ganglion
L L Wright, A J Smolen
Social Biology
|
January 1, 1985
Neurochemical mechanisms in the genetics of alcohol phenotypes
T N Smolen, A C Collins
Journal of Lipid Research
|
May 1, 1974
Permeability changes induced by peroxidation in liposomes prepared from human erythrocyte lipids
J E Smolen, S B Shohet
Journal of Pharmaceutical Sciences
|
March 1, 1977
Predictive conversion of in vitro drug dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarin
V F Smolen, R J Erb
The Journal of Experimental Medicine
|
September 14, 2016
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor
Eng M Tan, Josef S Smolen
Page
of 173